<DOC>
	<DOC>NCT00200005</DOC>
	<brief_summary>Multicenter European study to evaluate efficacy and safety of sacral nerve stimulation with InterStim Therapy to treat fecal incontinence or constipation</brief_summary>
	<brief_title>Sacral Nerve Stimulation for Anal Incontinence and Bowel Control</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>140 patients (7 study groups, up to 20 implanted patients per study group) Fecal Incontinence groups: Main Fecal incontinence (defined as incontinence to solid or liquid stool &gt; 1 / week); Failed biofeedback or medical therapy; Groups 1 5 patients with: Group 1) Circumferentially intact external anal sphincter, no previous surgery; Group 2) Circumferentially intact external anal sphincter after surgical repair; Group 3) Rectal prolapse repaired with a rectopexy; Group 4) Spinal injury including disc prolapse; Group 5) Sigmoid or partial rectal resection with colorectal or coloanal anastomosis Constipation groups: Main Chronic constipation (defined as &lt;/= 2 weekly bowel movements; and/or &gt;25% of bowel movements required straining; and/or &gt;25% of bowel movements patient did not feel empty afterwards) with symptoms more than 1 year Failed biofeedback or medical therapy; Groups 6 7 patients with: Group 6) Idiopathic slow transit constipation as proven on colonic transit studies; Group 7) Normal colonic transit studies but chronic constipation due to either pelvic floor dysfunction or disordered defecation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Slow transit constipation</keyword>
	<keyword>Fecal incontinence</keyword>
	<keyword>Constipation</keyword>
	<keyword>Idiopathic slow transit constipation</keyword>
	<keyword>Chronic constipation</keyword>
</DOC>